- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fuji lands CR deal with Premier group
Fuji lands CR deal with Premier groupFuji Medical Systems USA has agreed to a limited-time offer to sell its CR readers at special pricing to members of the Premier group purchasing organization. The agreement could bring more than $25 million
Fuji lands CR deal with Premier group
Fuji Medical Systems USA has agreed to a limited-time offer to sell its CR readers at special pricing to members of the Premier group purchasing organization. The agreement could bring more than $25 million in sales to the Stamford, CT-based vendor. Premier's members have until May 1 to take advantage of the deal, which covers Fuji's AC-3, FCR-5000, FCR-9000, and FCR-9501 CR systems.
While digital detectors have drawn attention in the radiology community, there is clearly a strong demand for CR. In fact, Fuji believes prospective purchasers are increasingly looking to use CR in diverse types of applications, said Clay Larsen, managing director at Fuji.
"Until now, CR has been looked at primarily as a great solution for ICU/CCU, and the ER department," Larsen said. "Now the adoption rate is heating up to place the systems in total departmental solutions, trying to get the entire radiographic case load into a digital format. The adoption rate is getting a broader footprint into institutions."
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
